This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07965/identifier/pdb/
n4http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07965/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07965/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07965/identifier/drugbank/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07965/identifier/chemspider/

Statements

Subject Item
n2:DB07965
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07965 n7:DB07965
dcterms:title
6-(CYCLOHEXYLAMINO)-9-[2-(4-METHYLPIPERAZIN-1-YL)-ETHYL]-9H-PURINE-2-CARBONITRILE
adms:identifier
n9:DB07965 n10:IHE n11:4450743 n13:5288616 n14:99444436
n5:IUPAC-Name
n6:271B50C0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B50C6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B50C5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B50C2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B50C3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B50C4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B50BE-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B50BF-363D-11E5-9242-09173F13E4C5 n6:271B50BC-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B50BD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B50CC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B50CD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B50C7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B50C8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B50CA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B50C9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B50CB-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B50D2-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B50D4-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B50D5-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B50D1-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B50D0-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B50D3-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B50C1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B50CE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B50CF-363D-11E5-9242-09173F13E4C5